200 related articles for article (PubMed ID: 36308822)
1. The DNA damage induced immune response: Implications for cancer therapy.
Barros EM; McIntosh SA; Savage KI
DNA Repair (Amst); 2022 Dec; 120():103409. PubMed ID: 36308822
[TBL] [Abstract][Full Text] [Related]
2. Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy.
Huang JL; Chang YT; Hong ZY; Lin CS
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328658
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the Cell-Intrinsic DNA Damage Response by the Innate Immune Machinery.
Hayman TJ; Glazer PM
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884568
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory signaling in genomically instable cancers.
Talens F; Van Vugt MATM
Cell Cycle; 2019 Aug; 18(16):1830-1848. PubMed ID: 31260383
[TBL] [Abstract][Full Text] [Related]
5. Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy.
Ye Z; Shi Y; Lees-Miller SP; Tainer JA
Front Immunol; 2021; 12():797880. PubMed ID: 34970273
[TBL] [Abstract][Full Text] [Related]
6. Replication Stress, DNA Damage, Inflammatory Cytokines and Innate Immune Response.
Ragu S; Matos-Rodrigues G; Lopez BS
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32283785
[TBL] [Abstract][Full Text] [Related]
7. DNA Damage and Cancer Immunotherapy: A STING in the Tale.
Reisländer T; Groelly FJ; Tarsounas M
Mol Cell; 2020 Oct; 80(1):21-28. PubMed ID: 32810436
[TBL] [Abstract][Full Text] [Related]
8. Targeting DNA damage response components induces enhanced STING-dependent type-I IFN response in ATM deficient cancer cells and drives dendritic cell activation.
Lopez-Pelaez M; Young L; Vazquez-Chantada M; Nelson N; Durant S; Wilkinson RW; Poon E; Gaspar M; Valge-Archer V; Smith P; Dovedi SJ
Oncoimmunology; 2022; 11(1):2117321. PubMed ID: 36117525
[TBL] [Abstract][Full Text] [Related]
9. Type-I Interferon Signaling in Fanconi Anemia.
Landelouci K; Sinha S; Pépin G
Front Cell Infect Microbiol; 2022; 12():820273. PubMed ID: 35198459
[TBL] [Abstract][Full Text] [Related]
10. The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy.
Shi C; Qin K; Lin A; Jiang A; Cheng Q; Liu Z; Zhang J; Luo P
J Exp Clin Cancer Res; 2022 Sep; 41(1):268. PubMed ID: 36071479
[TBL] [Abstract][Full Text] [Related]
11. Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches.
Khoo LT; Chen LY
EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30446584
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
Francies FZ; Wainwright R; Poole J; De Leeneer K; Coene I; Wieme G; Poirel HA; Brichard B; Vermeulen S; Vral A; Slabbert J; Claes K; Baeyens A
DNA Repair (Amst); 2018 Jan; 61():17-24. PubMed ID: 29154021
[TBL] [Abstract][Full Text] [Related]
13. cGAS-STING signalling in cancer: striking a balance with chromosomal instability.
Beernaert B; Parkes EE
Biochem Soc Trans; 2023 Apr; 51(2):539-555. PubMed ID: 36876871
[TBL] [Abstract][Full Text] [Related]
14. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
[TBL] [Abstract][Full Text] [Related]
15. Upregulated ATM gene expression and activated DNA crosslink-induced damage response checkpoint in Fanconi anemia: implications for carcinogenesis.
Yamamoto K; Nihrane A; Aglipay J; Sironi J; Arkin S; Lipton JM; Ouchi T; Liu JM
Mol Med; 2008; 14(3-4):167-74. PubMed ID: 18224251
[TBL] [Abstract][Full Text] [Related]
16. A Boolean network model of the FA/BRCA pathway.
Rodríguez A; Sosa D; Torres L; Molina B; Frías S; Mendoza L
Bioinformatics; 2012 Mar; 28(6):858-66. PubMed ID: 22267503
[TBL] [Abstract][Full Text] [Related]
17. The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer.
Li T; Chen ZJ
J Exp Med; 2018 May; 215(5):1287-1299. PubMed ID: 29622565
[TBL] [Abstract][Full Text] [Related]
18. Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control.
Concannon K; Morris BB; Gay CM; Byers LA
Mol Cell; 2023 Mar; 83(5):660-680. PubMed ID: 36669489
[TBL] [Abstract][Full Text] [Related]
19. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
[TBL] [Abstract][Full Text] [Related]
20. STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway.
Cheradame L; Guerrera IC; Gaston J; Schmitt A; Jung V; Goudin N; Pouillard M; Radosevic-Robin N; Modesti M; Judde JG; Cairo S; Goffin V
Oncogene; 2021 Dec; 40(49):6627-6640. PubMed ID: 34625708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
